Compare HSLV & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HSLV | PRGO |
|---|---|---|
| Founded | N/A | 1887 |
| Country | Canada | Ireland |
| Employees | 51 | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.5B |
| IPO Year | N/A | 2013 |
| Metric | HSLV | PRGO |
|---|---|---|
| Price | $5.87 | $11.54 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $19.33 |
| AVG Volume (30 Days) | 208.9K | ★ 2.8M |
| Earning Date | 05-28-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 10.10% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $800,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $37.60 | $1.02 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.72 | $9.23 |
| 52 Week High | $6.77 | $28.44 |
| Indicator | HSLV | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 42.80 | 53.80 |
| Support Level | $4.72 | $10.40 |
| Resistance Level | $6.00 | $12.13 |
| Average True Range (ATR) | 0.35 | 0.42 |
| MACD | -0.04 | 0.07 |
| Stochastic Oscillator | 14.29 | 63.87 |
Highlander Silver Corp. is a mineral exploration company engaged in the acquisition, exploration and evaluation of mineral properties located in Peru. It is focused on advancing the bonanza grade San Luis gold-silver project that is located in Central Peru. The company has determined that it has one operating segment, being the exploration of mineral properties.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.